Lomustine Combined With Anlotinib as Interventional Therapy for Extensive-stage Small Cell Lung Cancer Resistant to Second-line and Above Treatment
Clinical trial NCT07632209 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07632209
- Sponsor
- Yayi He
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-01
- Primary completion
- 2028-06-01
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.